- Home
- LNTH vs HLNE Comparison
LNTH vs HLNE Comparison
Compare LNTH & HLNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LNTH
- HLNE
- Stock Information
- Founded
- LNTH 1956
- HLNE 1991
- Country
- LNTH United States
- HLNE United States
- Employees
- LNTH N/A
- HLNE N/A
- Industry
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- HLNE Investment Managers
- Sector
- LNTH Health Care
- HLNE Finance
- Exchange
- LNTH Nasdaq
- HLNE Nasdaq
- Market Cap
- LNTH 7.5B
- HLNE 6.0B
- IPO Year
- LNTH 2015
- HLNE 2017
- Fundamental
- Price
- LNTH $96.16
- HLNE $147.08
- Analyst Decision
- LNTH Strong Buy
- HLNE Hold
- Analyst Count
- LNTH 6
- HLNE 7
- Target Price
- LNTH $129.83
- HLNE $160.57
- AVG Volume (30 Days)
- LNTH 864.1K
- HLNE 546.4K
- Earning Date
- LNTH 05-01-2025
- HLNE 05-22-2025
- Dividend Yield
- LNTH N/A
- HLNE 1.30%
- EPS Growth
- LNTH N/A
- HLNE 66.80
- EPS
- LNTH 4.36
- HLNE 5.42
- Revenue
- LNTH $1,533,910,000.00
- HLNE $691,656,000.00
- Revenue This Year
- LNTH $6.59
- HLNE $25.46
- Revenue Next Year
- LNTH $11.80
- HLNE $8.07
- P/E Ratio
- LNTH $22.06
- HLNE $27.83
- Revenue Growth
- LNTH 18.32
- HLNE 41.16
- 52 Week Low
- LNTH $58.16
- HLNE $108.34
- 52 Week High
- LNTH $126.89
- HLNE $203.72
- Technical
- Relative Strength Index (RSI)
- LNTH 48.12
- HLNE 45.83
- Support Level
- LNTH $94.80
- HLNE $145.34
- Resistance Level
- LNTH $100.73
- HLNE $158.16
- Average True Range (ATR)
- LNTH 3.97
- HLNE 4.98
- MACD
- LNTH -0.97
- HLNE 0.92
- Stochastic Oscillator
- LNTH 8.41
- HLNE 47.69
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.
About HLNE Hamilton Lane Incorporated
Hamilton Lane Inc is a private market investment solutions provider in the United States. It works with its clients to conceive, structure, build out, manage and monitor portfolios of private markets funds and direct investments, and it helps them access a set of such investment opportunities around the world. The company offers a range of investment solutions across a range of private markets, including private equity, private credit, real estate, infrastructure, natural resources, growth equity, venture capital and impact. The company generate revenues mainly from management and advisory fees.